Etid klinik pou Dyabèt nan Oklahoma
4 etid pou Dyabèt ap chèche patisipan nan sit nan Oklahoma.
Tèks ofisyèl etid la (Anglè)
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Chickasha
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- University of Oklahoma Health Sciences Center, Oklahoma City
Ap rekriteFaz 2
Laj 6 a 17 · Tout sèks · Mizajou Aug 13, 2026 · NCT07224321Fiber mHealth Intervention for Prediabetes
- University of Oklahoma Health Campus, Tulsa
Ap rekrite
Laj 18 a 39 · Tout sèks · Mizajou Jun 1, 2026 · NCT07491653Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
- University of Oklahoma Health Sciences Center, Oklahoma City
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Apr 1, 2026 · NCT05174052Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.